Washington State Pharmacy CommissionWSR 26-17-041WashingtonSep 15, 2026
Illustrative example. The document and sources here are fictional and were written to demonstrate the product.
Plain-English summary
Pharmacists in Washington may dispense Rhinovex without a prescription starting in 2027, with an age limit, a required consultation, and quantity limits.
The Commission adopted a final rule allowing pharmacists to dispense rhinovexamide (sold as Rhinovex) to adults without a prescription. This is pharmacist-dispensed access, not open shelf sale.
The rule takes effect January 1, 2027, but pharmacists cannot dispense until they complete a Commission-approved training program, which the Commission must publish by April 1, 2027. Practical availability may therefore begin later than the effective date.
AI-assisted summary. Every finding below links to the exact source text.
Adults 18 and older may obtain Rhinovex from a pharmacist without a prescription.
The rule takes effect January 1, 2027, but dispensing requires pharmacist training that is due by April 1, 2027.
The effective date and the date people can actually get it may differ.
Each purchase requires a documented pharmacist consultation.
Supply is limited to 30 days in any 90-day period, and only in person.
Details that are easy to miss. Length or complexity is not treated as a sign of intent.
Delayed provision
The rule takes effect January 1, 2027. A pharmacist may not dispense until completing the approved training, which the Commission must publish by April 1, 2027.
Why it may matter · interpretation
The earliest realistic date to obtain it may be April 2027 or later, depending on how quickly pharmacists complete the training.
Condition
Before dispensing, the pharmacist must complete a screening consultation using the Commission's protocol and record it in the patient record.
Why it may matter · interpretation
This adds a step and time to each purchase compared with shelf sale.
Limitation
No more than a 30-day supply may be dispensed to a patient in any 90-day period.
Limitation
Dispensing under this section must occur in a pharmacy. Telehealth and mail order are not authorized under it.
Why it may matter · interpretation
People far from a pharmacy may not benefit from this rule as written.
Adult patients (18+)
May obtain the medication without a prescription after a pharmacist consultation.
Pharmacists and pharmacies
Must complete approved training, run the screening consultation, and keep records before dispensing.
Mail-order and telehealth providers
Not covered by this section; dispensing under it must occur in a pharmacy.
Timing · Effective date
Jan 1, 2027
The recordkeeping section takes effect later, July 1, 2027.
Implementation · Training program due
Apr 1, 2027
Pharmacists may not dispense under this rule until they complete it.
Eligibility · Minimum age
18+
Patients under 18 are outside this rule.
Other · Quantity limit
30 days / 90
No more than a 30-day supply in any 90-day period.
What the material asserts, set beside what the underlying source says.
The bulletin says people can buy Rhinovex “over the counter starting January 1.”
Claim as written
Washingtonians will be able to buy Rhinovex over the counter starting January 1.
Source says
A pharmacist may not dispense under this section until the pharmacist has completed the commission-approved training program. The commission shall publish the approved program by April 1, 2027.
Partly consistentThe rule is effective January 1, but dispensing requires completed pharmacist training due April 1, and a consultation is required.
Places where statements sit uneasily against each other or against the source. Listed because both sides are quoted, not because either is presumed wrong.
The bulletin implies availability from January 1, while the rule conditions dispensing on training that need only be published by April 1.
Describes wording choices. It does not judge intent or call anything “biased.”
The trade bulletin uses “over the counter,” which can suggest self-service shelf access. The rule provides for pharmacist dispensing after a consultation.
Context that could affect interpretation but doesn't appear in the material reviewed. An absence is not evidence of intent.
In the rule text reviewed, there is no statement on whether insurers must cover the medication or what pharmacies may charge.
Cost and coverage affect whether the change is practically useful. This may be addressed elsewhere.
Procedural, legal, or policy background that helps in reading the text.
A state agency adopts a final rule after a proposal and public comment. The rule's own effective-date section, not the adoption date, controls when it applies.
Primary sources are official records. Secondary sources are reporting, commentary, or organizational material. Findings cite excerpts from these.
WSR 26-17-041: Pharmacist-dispensed access to rhinovexamide (final rule)
Washington State Pharmacy CommissionFinal ruleSep 15, 20266 cited excerpts
lawfilesext.leg.wa.gov (opens in a new tab)Members bulletin: New access to Rhinovex
State pharmacy trade associationOrganization bulletinSep 16, 20261 cited excerpt
No link available
Labels describe how well a finding is backed by its cited text. There are no scores or percentages.
Provenance for this analysis. Private model reasoning is not shown.
WSR 26-17-041: Pharmacist-dispensed access to rhinovexamide (final rule) · § 246-945-A010(1)
A pharmacist may dispense rhinovexamide without a prescription to a patient who is 18 years of age or older, subject to the requirements of this section.
WSR 26-17-041: Pharmacist-dispensed access to rhinovexamide (final rule) · § 246-945-A010(2)
Before dispensing, the pharmacist shall complete a consultation with the patient using the commission's screening protocol and shall document the consultation in the patient record.
WSR 26-17-041: Pharmacist-dispensed access to rhinovexamide (final rule) · § 246-945-A010(3)
Not more than a 30-day supply may be dispensed to a patient in any 90-day period.
WSR 26-17-041: Pharmacist-dispensed access to rhinovexamide (final rule) · § 246-945-A010(4)
Dispensing under this section must occur in a pharmacy. This section does not authorize dispensing by telehealth or mail order.
WSR 26-17-041: Pharmacist-dispensed access to rhinovexamide (final rule) · § 246-945-A020
A pharmacist may not dispense under this section until the pharmacist has completed the commission-approved training program. The commission shall publish the approved program by April 1, 2027.
WSR 26-17-041: Pharmacist-dispensed access to rhinovexamide (final rule) · § 3
This rule takes effect January 1, 2027, except that section 5, relating to recordkeeping, takes effect July 1, 2027.
Members bulletin: New access to Rhinovex
Washingtonians will be able to buy Rhinovex over the counter starting January 1.